Header Logo

Connection

Kathleen Moore to Diarrhea

Back to Details
This is a "connection" page, showing publications Kathleen Moore has written about Diarrhea.
Kathleen Moore
Connection Strength
0.149
Diarrhea
  1. Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer. Gynecol Oncol. 2018 10; 151(1):46-52.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.